share_log

Oppenheimer Reiterates Outperform on Tyra Biosciences, Maintains $25 Price Target

Benzinga ·  May 8, 2023 08:48

Oppenheimer analyst Matthew Biegler reiterates Tyra Biosciences (NASDAQ:TYRA) with a Outperform and maintains $25 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment